Mesangial cells are responsible for orchestrating the renal podocytes injury in the context of malignant hypertension

Nephrology

Volumn 18, Issue 4, 2013, Pages 292-298

  Berman, Sylvia ^a,b   Abu Hamad, Ramzia ^a,b   Efrati, Shai ^a,b  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Angiotensin II; hyperglycaemia; malignant hypertension; mesangial cell; podocyte

Indexed keywords

ANGIOTENSIN II;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; FETUS; HYDROSTATIC PRESSURE; HYPERGLYCEMIA; IN VITRO STUDY; MALIGNANT HYPERTENSION; MESANGIUM CELL; NONHUMAN; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; RAT;

ANGIOTENSIN II; ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; GLUCOSE; HYDROSTATIC PRESSURE; HYPERGLYCEMIA; HYPERTENSION, MALIGNANT; MESANGIAL CELLS; PARACRINE COMMUNICATION; PODOCYTES; RATS;

EID: 84875711146     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12043     Document Type: Article

References (25)

1. Dustan HP, Schneckloth RE, Corcoran AC, Page IH,. The effectiveness of long-term treatment of malignant hypertension. Circulation 1958; 18 (4 Part 1): 644-651.
2. Vaughan CJ, Delanty N,. Hypertensive emergencies. Lancet 2000; 356 (9227): 411-417.
3. Lip GY, Beevers M, Beevers DG,. Does renal function improve after diagnosis of malignant phase hypertension? J. Hypertens. 1997; 15: 1309-1315.
4. Efrati S, Berman S, Tov YS, Averbukh Z, Weissgarten J,. Hyperglycemia alters renal cell responsiveness to pressure in a model of malignant hypertension. J. Hypertens. 2009; 27: 365-375.
5. Efrati S, Berman S, Goldfinger N, et al. Enhanced angiotensin II production by renal mesangium is responsible for apoptosis/proliferation of endothelial and epithelial cells in a model of malignant hypertension. J. Hypertens. 2007; 25: 1041-1052.
6. Saleem MA, O'Hare MJ, Reiser J, et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J. Am. Soc. Nephrol. 2002; 13: 630-638.
7. Stitt-Cavanagh E, MacLeod L, Kennedy C,. The podocyte in diabetic kidney disease. ScientificWorldJournal 2009; 9: 1127-1139.
8. Yoo TH, Li JJ, Kim JJ, et al. Activation of the renin-angiotensin system within podocytes in diabetes. Kidney Int. 2007; 71: 1019-1027.
9. Huber TB, Reinhardt HC, Exner M, et al. Expression of functional CCR and CXCR chemokine receptors in podocytes. J. Immunol. 2002; 168: 6244-6252.
10. Menini S, Iacobini C, Oddi G, et al. Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: Role in the development of diabetic glomerular disease. Diabetologia 2007; 50: 2591-2599.
11. Park SH, Choi HJ, Lee JH, Woo CH, Kim JH, Han HJ,. High glucose inhibits renal proximal tubule cell proliferation and involves PKC, oxidative stress, and TGF-beta 1. Kidney Int. 2001; 59: 1695-1705.
12. Kane CD, Greenhalgh DG,. Expression and localization of p53 and bcl-2 in healing wounds in diabetic and nondiabetic mice. Wound Repair Regen. 2000; 8: 45-58.
13. Wang N, Fan Y, Ni P, et al. High glucose effect on the role of CD146 in human proximal tubular epithelial cells in vitro. J. Nephrol. 2008; 21: 931-940.
14. Ziyadeh FN, Snipes ER, Watanabe M, Alvarez RJ, Goldfarb S, Haverty TP,. High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am. J. Physiol. 1990; 259 (4 Pt 2): F704-714.
15. Kriz W, Hahnel B, Rosener S, Elger M,. Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis. Kidney Int. 1995; 48: 1435-1450.
16. Miyauchi M, Toyoda M, Kobayashi K, et al. Hypertrophy and loss of podocytes in diabetic nephropathy. Intern Med. 2009; 48: 1615-1620.
17. Scott-Drechsel DE, Rugonyi S, Marks DL, Thornburg KL, Hinds MT,. Hyperglycemia slows embryonic growth and suppresses cell cycle via cyclin D1 and p21. Diabetes 2013; 62: 234-242.
18. Lai KN, Leung JC, Chan LY, et al. Activation of podocytes by mesangial-derived TNF-alpha: Glomerulo-podocytic communication in IgA nephropathy. Am. J. Physiol. Renal Physiol. 2008; 294 (4): F945-955.
19. Lee HS, Song CY,. Differential role of mesangial cells and podocytes in TGF-beta-induced mesangial matrix synthesis in chronic glomerular disease. Histol. Histopathol. 2009; 24: 901-908.
20. Lee HS,. Paracrine role for TGF-beta-induced CTGF and VEGF in mesangial matrix expansion in progressive glomerular disease. Histol. Histopathol. 2012; 27: 1131-1141.
21. Klahr S, Morrissey J,. Angiotensin II and gene expression in the kidney. Am. J. Kidney Dis. 1998; 31: 171-176.
22. Brenner, &, Rector,. The Kidney (textbook), 8th edn, Section VII, chapters 42-43. Philadelphia: Elsevier Health Sciences, 2007.
23. Stockand JD, Sansom SC,. Regulation of filtration rate by glomerular mesangial cells in health and diabetic renal disease. Am. J. Kidney Dis. 1997; 29: 971-981.
24. Stockand JD, Sansom SC,. Glomerular mesangial cells: Electrophysiology and regulation of contraction. Physiol. Rev. 1998; 78: 723-744.
25. Kriz W, LeHir M,. Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int. 2005; 67: 404-419.